Many complications have been reported over tattoos, some of which are tumours, such as dermatofibromas. It is important to establish a differential diagnosis because they can resemble other malignant lesions as dermatofibrosarcoma protuberans. We report the development of a dermatofibroma in a 21-year-old man with a tattoo painted two years ago.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190120PMC
http://dx.doi.org/10.1155/2014/745304DOI Listing

Publication Analysis

Top Keywords

dermatofibroma arising
4
arising black
4
black tattoo
4
tattoo complications
4
complications reported
4
reported tattoos
4
tattoos tumours
4
tumours dermatofibromas
4
dermatofibromas establish
4
establish differential
4

Similar Publications

Benign fibrous histiocytoma (BFH) is a rare mesenchymal tumor, with its deep variant (DBFH) accounting for only 1%-2% of cases. DBFH typically arises in the limbs, head, and neck, and usually measures under 12 cm. MRI can suggest the diagnosis by detailing the tumor's location and internal features.

View Article and Find Full Text PDF

Renal leiomyomas are rare benign mesenchymal tumors that arise from the smooth muscle cells in the renal capsule, renal pelvis, and the smooth muscles of vessels in the kidney. They are usually found by accident during autopsies or on different imaging modalities made on other occasions. The clinical presentation may include hematuria and abdominal or flank pain, although renal leiomyomas are most frequently asymptomatic.

View Article and Find Full Text PDF

Background: Hepatic hemangioma represents the most frequent benign tumor originating from the liver. When the tumor exceeds 10 cm, and in some studies 4 or 5 cm, it is considered giant, which accounts for 10% of all hemangiomas arising from the liver. Histologically, Sclerosing hepatic hemangioma, in particular, is an exceedingly rare subtype of hemangioma.

View Article and Find Full Text PDF

Sarcomas arising in the skin are rare but potentially fatal. These tumours originate from mesenchymal cells and can be divided between those that arise in soft tissue and those arising from bone. General guidelines exist for the management of soft-tissue sarcomas; however, there are no specific guidelines for cutaneous sarcomas.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!